drugset / Trial / NCT05070650
Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold
RandomizedParallel-groupDouble-blindTreatment
Summary
Prospective, randomized, multinational, multicenter, double-blind trial in 2 parallel groups of patients
Timeline
- Start
- 2024-09-20
- Primary completion
- 2025-04-30
- Completion
- 2025-04-30
Outcome
Outcome not reported
Stopped (Enrollment): “Sandoz has decided to withdraw the clinical study due to internal business reasons. No patients were enrolled in any of the participating countries.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 500 mg | Oral |
| Subject | Acetylcysteine | Other / unclassified | 200 mg | Oral |
| Subject | Phenylephrine | Small molecule | 10 mg | Oral |